This selected patient cohort had a median age of 12 years (range: 1–17 years); the blasts predominantly belonged to the AML subtypes M1/M2 and most commonly carried the often co-occurring mutation FLT3-ITD (Table S6). The gene discussed is FLT3; the disease is acute myeloid leukemia.